CellTraffix Inc. is a privately held development-stage medical technology company pioneering new devices for diagnosis and treatment of human diseases.  CellTraffix is focused on bringing novel kits and therapeutic products to market to serve the oncology and adult stem cell markets.

For a detailed description of the technology, read Cancer Killing Invention Also Harvests Stem Cells about the work done by CellTraffix Scientific Advisor, Michael King, Associate Professor at the University of Rochester, Biomedical Engineering department.